CLINICAL_TRIALS
trial_result
· 2020-11-24
Clinical Trial Update: Binge Eating Liraglutide Intervention [Phase 3]
Summary
Phase 3 clinical trial of liraglutide for binge-eating disorder was terminated; results were posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kelly Allison | Conditions: Binge-Eating Disorder | Phase 3 | Status: TERMINATED | Results posted: 2020-11-24